Zimmer Biomet Holdings, Inc. (ZBH) fundamentals from SEC filings — revenue $8.2B, net margin 8.6%, diluted EPS $3.55 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6.8B | $6.9B | $7.4B | $7.7B | $8.2B |
| Net income | $401.6M | $231.4M | $1.0B | $903.8M | $705.1M |
| Net margin | 5.9% | 3.3% | 13.8% | 11.8% | 8.6% |
| Diluted EPS | $1.91 | $1.10 | $4.88 | $4.43 | $3.55 |
| Free cash flow | $1.4B | $1.2B | $1.3B | $1.3B | $1.5B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home